COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategies

Jilian Dong; Ruida Chen; Hanhe Zhao; Yirui Zhu

doi:10.1016/j.aopr.2022.11.001

您当前的位置：

首页 >

文章列表页 >

COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategies

Review | 更新时间：2023-11-15

- COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategies
- COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategies
- 眼科实践与研究新进展 2023年3卷第1期页码：33-38
- 作者机构：
  
  1. ,Nanjing,China
  2. ,China
  3. ,Hangzhou,China
- 作者简介：
- 基金信息：
- DOI：10.1016/j.aopr.2022.11.001
  中图分类号：
扫描看全文
COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategies[J]. 眼科实践与研究新进展, 2023,3(1):33-38.

Jilian Dong, Ruida Chen, Hanhe Zhao, et al. COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategies[J]. AOPR, 2023,3(1):33-38.
COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategies[J]. 眼科实践与研究新进展, 2023,3(1):33-38. DOI： 10.1016/j.aopr.2022.11.001.

Jilian Dong, Ruida Chen, Hanhe Zhao, et al. COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategies[J]. AOPR, 2023,3(1):33-38. DOI： 10.1016/j.aopr.2022.11.001.

摘要

Background,The novel severe acute respiratory syndrome coronavins 2 (SARS-CoV-2) led to the severe Corona Virus Disease 2019 (COVID-19) outbreak that started in December 2019 in China and caused enormous health and economic problems worldwide. Over time, SARS-CoV-2 has demonstrated the capacity for mutation. As the most prevalent new coronavirus variety worldwide, the Omicron variant has supplanted the Delta variant. The COVID-19 primarily damages the immune system and the lungs, but it can also harm other organs secondarily, depending on the patients' co-existing conditions.,Main Text,COVID-19 is associated with ophthalmic manifestations such as conjunctival congestion, tear overflow, and conjunctival edema, with the majority of eye complications occurring in patients with severe infection. The virus may make a patient more susceptible to thrombotic conditions that affect venous and arterial circulation. Meanwhile, it can lead to efferent complications and mucormycosis which is more common in patients with diabetes or who have critical or severe SARS-CoV-2 infection. Significantly, there are a number of ocular side effects following the COVID-19 vaccination, such as herpetic keratitis and facial nerve palsy, which have been reported. These side effects may be caused by the vaccinations' propensity to trigger autoimmune symptoms or thromboembolic events. At present, large-scale nucleic acid testing mainly relies on nasopharyngeal swabs and throat swabs. Tear samples and conjunctival swabs may be helpful samples for the diagnosis of ocular SARS-CoV-2 infection. The eye could be a new route of infection, and finding ways such as effective environmental disinfection, scientific administrative control management, qualified personal protection and other measures to protect the eyes could further reduce the risk of infection.,Conclusions,This review aims to sum up the ocular complications of COVID-19, the possible pathogenesis, and preventive strategies to protect ophthalmology practitioners and patients by reviewing the currently available literature on the topic.

Abstract

关键词

Keywords

COVID-19Ocular manifestationsDiagnostic toolsPrevention strategies

references

1 N Zhu, D Zhang, W Wang, et al.A novel coronavirus from patients with pneumonia in China N Engl J Med, 382 (8) (2019), pp. 727-733, 10.1056/NEJMoa2001017 Feb 20 2020

2 WHO Coronavirus (COVID-19) Dashboard https://covid19.who.int/ (2022)

3 WJ Wiersinga, A Rhodes, AC Cheng, et al.Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review JAMA, 324 (8) (2020), pp. 782-793, 10.1001/jama.2020.12839 Aug 25

4 CLX JungangInterpretation of “the diagnosis and treatment plan for COVID-19(the seventh trial edition)”(in Chinese) Herald of Med, 39 (39) (2020), pp. 613-615, 10.3870/j.issn.1004-0781.2020.05.00

5 M Hoffmann, H Kleine-Weber, S Schroeder, et al.SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Apr 16 Cell, 181 (2) (2020), pp. 271-280, 10.1016/j.cell.2020.02.052 e8

6 R Cantón, P De Lucas Ramos, A García-Botella, et al.New variants of SARS-CoV-2 Rev Española Quimioter : Pub Offi de la Sociedad Española Quimioter, 34 (5) (2021), pp. 419-428, 10.37201/req/071.2021 Oct

7 A Aleem, AB Akbar Samad, AK SlenkerEmerging Variants of SARS-CoV-2 and Novel Therapeutics against Coronavirus (COVID-19). StatPearls StatPearls Publishing, Copyright © 2022, StatPearls Publishing LLC. (2022)

8 NG Davies, RC Barnard, CI Jarvis, et al.Association of tiered restrictions and a second lockdown with COVID-19 deaths and hospital admissions in England: a modelling study Lancet Infect Dis. Apr, 21 (4) (2021), pp. 482-492, 10.1016/S1473-3099(20)30984-1

9 DJ Grint, K Wing, E Williamson, et al.Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February Euro Surveill : Bulletin Eur sur les maladies transmissibles = Eur Communicable Disease Bulletin, 26 (11) (2021), 10.2807/1560-7917.Es.2021.26.11.2100256 Mar

10 E Volz, S Mishra, M Chand, et al.Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England Nature, 593 (7858) (2021), pp. 266-269, 10.1038/s41586-021-03470-x May

11 H Song, G Fan, S Zhao, et al.Forecast of the COVID-19 trend in India: a simple modelling approach. Mathematical biosciences and engineering MBE, 18 (6) (2021), pp. 9775-9786, 10.3934/mbe.2021479 Nov 5

12 DN Fisman, AR TuiteEvaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada CMAJ (Can Med Assoc J), 193 (42) (2021), pp. E1619-E1625, 10.1503/cmaj.211248 Oct 25

13 WT Harvey, AM Carabelli, B Jackson, et al.SARS-CoV-2 variants, spike mutations and immune escape Nat Rev Microbiol, 19 (7) (2021), pp. 409-424, 10.1038/s41579-021-00573-0 Jul

14 N Wolter, W Jassat, S Walaza, et al.Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study Lancet (London, England), 399 (10323) (2022), pp. 437-446, 10.1016/s0140-6736(22)00017-4 Jan 29

15 S Kannan, P Shaik Syed Ali, A SheezaOmicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review Eur Rev Med Pharmacol Sci, 25 (24) (2021), pp. 8019-8022, 10.26355/eurrev_202112_27653 Dec

16 T SinghalThe emergence of omicron: challenging times are here again Indian J Pediatr (2022), pp. 1-7, 10.1007/s12098-022-04077-4 Jan 13

17 SA Meo, AS Meo, FF Al-Jassir, et al.Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics Eur Rev Med Pharmacol Sci, 25 (24) (2021), pp. 8012-8018, 10.26355/eurrev_202112_27652 Dec

18 MY Li, L Li, Y Zhang, et al.Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues Infectious Dis poverty, 9 (1) (2020), p. 45, 10.1186/s40249-020-00662-x Apr 28

19 Dan PX Sun, Lin Liu, Canrong NiExpression of SARS coronavirus S protein functional receptor ACE2 in human and rabbit cornea and conjunctiva(in Chinese) Recent Adv Ophthalmol, 24 (24) (2004), pp. 332-336, 10.3969/j.issn.1003-5141.2004.05.002

20 Y Zhou, Y Zeng, Y Tong, et al.Ophthalmologic Evidence against the Interpersonal Transmission of 2019 Novel Coronavirus through Conjunctiva medRxiv (2020) 2020.02.11.20021956

21 X Zhang, X Chen, L Chen, et al.The Infection Evidence of SARS-COV-2 in Ocular Surface: A Single-Center Cross-Sectional Study medRxiv (2020) 2020.02.26.20027938

22 I Seah, R AgrawalCan the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals Ocul Immunol Inflamm, 28 (3) (2020), pp. 391-395, 10.1080/09273948.2020.1738501 Apr 2

23 S Acharya, M Diamond, S Anwar, et al.Unique case of central retinal artery occlusion secondary to COVID-19 disease IDCases, 21 (2020), Article e00867, 10.1016/j.idcr.2020.e00867

24 OM Dumitrascu, O Volod, S Bose, et al.Acute ophthalmic artery occlusion in a COVID-19 patient on apixaban J Stroke Cerebrovasc Dis : Offi J Nation Stroke Assoc, 29 (8) (2020), Article 104982, 10.1016/j.jstrokecerebrovasdis.2020.104982 Aug

25 A Insausti-García, JA Reche-Sainz, C Ruiz-Arranz, et al., López Vázquez ÁPapillophlebitis in a COVID-19 patient: inflammation and hypercoagulable state Eur J Ophthalmol, 32 (1) (2022), pp. Np168-np172, 10.1177/1120672120947591 Jan

26 MF Landecho, JR Yuste, E Gándara, et al.COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? J Intern Med, 289 (1) (2021), pp. 116-120, 10.1111/joim.13156 Jan

27 A Ortiz-Seller, L Martínez Costa, A Hernández-Pons, et al.Ophthalmic and neuro-ophthalmic manifestations of coronavirus disease 2019 (COVID-19) Ocular immunol. Inflamm., 28 (8) (2020), pp. 1285-1289, 10.1080/09273948.2020.1817497 Nov.26

28 S Sanjay, PB Gowda, B Rao, et al.Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids J Ophthalmic Inflamm Infec, 11 (1) (2021), p. 14, 10.1186/s12348-021-00244-4 May 14

29 S Sanjay, D Mutalik, S Gowda, et al.Post coronavirus disease (COVID-19) reactivation of a quiescent unilateral anterior uveitis SN Comprehen Clinic Med, 3 (9) (2021), pp. 1843-1847, 10.1007/s42399-021-00985-2

30 S Sanjay, P Srinivasan, C Jayadev, et al.Post COVID-19 ophthalmic manifestations in an asian Indian male Ocul Immunol Inflamm, 29 (4) (2021), pp. 656-661, 10.1080/09273948.2020.1870147 May 19

31 D Shroff, R Narula, N Atri, et al.Endogenous fungal endophthalmitis following intensive corticosteroid therapy in severe COVID-19 disease Indian J Ophthalmol, 69 (7) (2021), pp. 1909-1914, 10.4103/ijo.IJO_592_21 Jul

32 SKA Sanjay, S Agrawal, P MahendradasUnilateral acute anterior sclero-uveitis preceding Corona virus disease (COVID-19) Pan Am J Ophthalmol, 4 (2022), p. 26

33 EH Leung, J Fan, HW Flynn Jr., et al.Ocular and systemic complications of COVID-19: impact on patients and healthcare Clin Ophthalmol, 16 (2022), pp. 1-13, 10.2147/opth.S336963

34 P Wu, F Duan, C Luo, et al.Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province, China JAMA Ophthalmol, 138 (5) (2020), pp. 575-578, 10.1001/jamaophthalmol.2020.1291 May 1

35 X Zhang, X Chen, L Chen, et al.The evidence of SARS-CoV-2 infection on ocular surface Ocul Surf. Jul, 18 (3) (2020), pp. 360-362, 10.1016/j.jtos.2020.03.010

36 L Loffredo, F Pacella, E Pacella, et al.Conjunctivitis and COVID-19: a meta-analysis J Med Virol, 92 (9) (2020), pp. 1413-1414, 10.1002/jmv.25938 Sep

37 K Aggarwal, A Agarwal, N Jaiswal, et al.Ocular surface manifestations of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis PLoS One, 15 (11) (2020), Article e0241661, 10.1371/journal.pone.0241661

38 SCL AuCentral retinal artery occlusion in COVID-19 Indian J Ophthalmol, 69 (10) (2021), pp. 2905-2906, 10.4103/ijo.IJO_1803_21 Oct

39 M Sen, SG Honavar, N Sharma, et al.COVID-19 and eye: a review of ophthalmic manifestations of COVID-19 Indian J Ophthalmol. Mar, 69 (3) (2021), pp. 488-509, 10.4103/ijo.IJO_297_21

40 B Bikdeli, MV Madhavan, D Jimenez, et al.COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review J Am Coll Cardiol, 75 (23) (2020), pp. 2950-2973, 10.1016/j.jacc.2020.04.031 Jun 16

41 PM Marinho, AAA Marcos, AC Romano, et al.Retinal findings in patients with COVID-19 Lancet (London, England), 395 (10237) (2020), p. 1610, 10.1016/s0140-6736(20)31014-x May 23

42 FT Collison, J CarrollSeeking clarity on retinal findings in patients with COVID-19 Lancet (London, England), 396 (10254) (2020), p. e38, 10.1016/s0140-6736(20)31917-6 Sep 19

43 LA Zago Filho, LH Lima, GB Melo, et al.Vitritis and outer retinal abnormalities in a patient with COVID-19 Ocul Immunol Inflamm, 28 (8) (2020), pp. 1298-1300, 10.1080/09273948.2020.1821898 Nov 16

44 MP Gonzalez, R Rios, M Pappaterra, et al.Reactivation of acute retinal necrosis following SARS-CoV-2 infection Case Reports in Ophthalmol Med (2021), 10.1155/2021/7336488 2021:7336488

45 A Gupta, B Dixit, K Stamoulas, et al.Atypical bilateral acute retinal necrosis in a coronavirus disease 2019 positive immunosuppressed patient Eur J Ophthalmol, 32 (1) (2022), pp. Np94-np96, 10.1177/1120672120974941 Jan

46 S Iwai, K Takayama, D Sora, et al.A case of acute retinal necrosis associated with reactivation of varicella zoster virus after COVID-19 vaccination Ocul Immunol Inflamm (2021), pp. 1-3, 10.1080/09273948.2021.2001541 Nov 22

47 SB Mishra, P Mahendradas, A Kawali, et al.Reactivation of varicella zoster infection presenting as acute retinal necrosis post COVID 19 vaccination in an Asian Indian male Eur J Ophthalmol (2021), Article 11206721211046485, 10.1177/11206721211046485 Sep 18

48 A Soni, R Narayanan, M Tyagi, et al.Acute Retinal Necrosis as a presenting ophthalmic manifestation in COVID 19 recovered patients Ocul Immunol Inflamm, 29 (4) (2021), pp. 722-725, 10.1080/09273948.2021.1938135 May 19

49 LI Mudie, JD Zick, MS Dacey, et al.Panuveitis following vaccination for COVID-19 Ocul Immunol Inflamm, 29 (4) (2021), pp. 741-742, 10.1080/09273948.2021.1949478 May 19

50 J Providência, C Fonseca, F Henriques, et al.Serpiginous choroiditis presenting after SARS-CoV-2 infection: a new immunological trigger? Eur J Ophthalmol, 32 (1) (2022), pp. Np97-np101, 10.1177/1120672120977817 Jan

51 Y Zhang, JM StewartRetinal and choroidal manifestations of COVID-19 Curr Opin Ophthalmol, 32 (6) (2021), pp. 536-540, 10.1097/icu.0000000000000801 Nov 1

52 M Dinkin, S SathiEfferent neuro-ophthalmic complications of coronavirus disease 2019 Curr Opin Ophthalmol, 33 (6) (2022), pp. 471-484, 10.1097/icu.0000000000000904 Nov 1

53 S Sarkar, T Gokhale, SS Choudhury, et al.COVID-19 and orbital mucormycosis Indian J Ophthalmol, 69 (4) (2021), pp. 1002-1004, 10.4103/ijo.IJO_3763_20 Apr

54 M Sen, S Lahane, TP Lahane, et al.Mucor in a viral land: a tale of two pathogens Indian J Ophthalmol, 69 (2) (2021), pp. 244-252, 10.4103/ijo.IJO_3774_20 Feb

55 A Mittal, N Mahajan, D Pal Singh Dhanota, et al.SARS-CoV-19-associated Rhino-orbital and cerebral mucormycosis: clinical and radiological presentations Med Mycol (9) (2022), p. 60, 10.1093/mmy/myac045 Sep 16

56 I Mahalaxmi, K Jayaramayya, D Venkatesan, et al.Mucormycosis: an opportunistic pathogen during COVID-19 Environ Res, 201 (2021), Article 111643, 10.1016/j.envres.2021.111643 Oct

57 A Bhattacharyya, P Sarma, DJ Sharma, et al.Rhino-orbital-cerebral-mucormycosis in COVID-19: a systematic review Indian J Pharmacol, 53 (4) (2021), pp. 317-327, 10.4103/ijp.ijp_419_21 Jul-Aug

58 XL Ng, BK Betzler, I Testi, et al.Ocular adverse events after COVID-19 vaccination Ocul Immunol Inflamm, 29 (6) (2021), pp. 1216-1224, 10.1080/09273948.2021.1976221 Aug 18

59 P Rai, BK Kumar, VK Deekshit, et al.Detection technologies and recent developments in the diagnosis of COVID-19 infection Appl Microbiol Biotechnol, 105 (2) (2021), pp. 441-455, 10.1007/s00253-020-11061-5 Jan

60 A Sharma, I Ahmad Farouk, SK LalCOVID-19: a review on the novel coronavirus disease evolution, transmission, detection, control and prevention Viruses, 13 (2) (2021), 10.3390/v13020202 Jan 29

61 JF Chan, S Yuan, KH Kok, et al.A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Lancet (London, England), 395 (10223) (2020), pp. 514-523, 10.1016/s0140-6736(20)30154-9 Feb 15

62 W Wang, Y Xu, R Gao, et al.Detection of SARS-CoV-2 in different types of clinical specimens JAMA, 323 (18) (2020), pp. 1843-1844, 10.1001/jama.2020.3786 May 12

63 J Xia, J Tong, M Liu, et al.Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection J Med Virol. Jun, 92 (6) (2020), pp. 589-594, 10.1002/jmv.25725

64 IYJ Seah, DE Anderson, AEZ Kang, et al.Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients Ophthalmol, 127 (7) (2020), pp. 977-979, 10.1016/j.ophtha.2020.03.026 Jul

65 H Qing, Z Li, Z Yang, et al.The possibility of COVID-19 transmission from eye to nose Acta Ophthalmol, 98 (3) (2020), p. e388, 10.1111/aos.14412 May

66 W Deng, L Bao, H Gao, et al.Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques Nat Commun, 11 (1) (2020), p. 4400, 10.1038/s41467-020-18149-6 Sep 2

67 A Bilgic, A Sudhalkar, JH Gonzalez-Cortes, et al.Endogenous endophthalmitis in the setting of COVID-19 infection: a case series Retina (Philadelphia, Pa, 41 (8) (2021), pp. 1709-1714, 10.1097/iae.0000000000003168 Aug 1

68 EH Koo, AO Eghrari, D Dzhaber, et al.Presence of SARS-CoV-2 viral RNA in aqueous humor of asymptomatic individuals Am J Ophthalmol, 230 (2021), pp. 151-155, 10.1016/j.ajo.2021.05.008 Oct

69 M Hada, K Khilnani, N Vyas, et al.Evaluating the presence of SARS-CoV-2 in the intraocular fluid of COVID-19 patients Indian J Ophthalmol, 69 (9) (2021), pp. 2503-2506, 10.4103/ijo.IJO_820_21 Sep

70 S Sanjay, VR Anandula, P Mahendradas, et al.Severe acute respiratory syndrome Corona virus and intraocular fluid sampling Indian J Ophthalmol, 69 (12) (2021), p. 3791, 10.4103/ijo.IJO_2298_21 Dec

71 Q Li, X Guan, P Wu, et al.Early transmission dynamics in wuhan, China, of novel coronavirus-infected pneumonia N Engl J Med, 382 (13) (2020), pp. 1199-1207, 10.1056/NEJMoa2001316 Mar 26

72 D LewisIs the coronavirus airborne? Experts can’t agree Nature, 580 (7802) (2020), p. 175, 10.1038/d41586-020-00974-w Apr

73 N van Doremalen, T Bushmaker, DH Morris, et al.Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1 N Engl J Med, 382 (16) (2020), pp. 1564-1567, 10.1056/NEJMc2004973 Apr 16

74 Ya SY Ye, M Yan, C Hu, et al.Novel coronavirus pneumonia combined with conjunctivitis: three cases report(in Chinese) Chinese J Experim Ophthalmol, 38 (38) (2020), pp. 242-244

75 JG Lawrenson, RJ BuckleyCOVID-19 and the eye Ophthalmic Physiol Opt, 40 (4) (2020), pp. 383-388, 10.1111/opo.12708 Jul

76 THT Lai, EWH Tang, SKY Chau, et al.Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv fur klinische und Experimentelle Ophthalmologie., 258 (5) (2020), pp. 1049-1055, 10.1007/s00417-020-04641-8 May

77 MS Attzs, BK LakhaniCOVID-19 and its effect on the provision of ophthalmic care in the United Kingdom Int J Clin Pract, 75 (7) (2021), Article e14052, 10.1111/ijcp.14052 Jul

78 A Davies, KA Thompson, K Giri, et al.Testing the efficacy of homemade masks: would they protect in an influenza pandemic? Disaster Med Public Health Prep, 7 (4) (2013), pp. 413-418, 10.1017/dmp.2013.43 Aug

79 X Wang, Z Pan, Z ChengAssociation between 2019-nCoV transmission and N95 respirator use J Hosp Infect, 105 (1) (2020), pp. 104-105, 10.1016/j.jhin.2020.02.021 May

80 LJ Radonovich Jr., MS Simberkoff, MT Bessesen, et al.N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial Jama, 322 (9) (2019), pp. 824-833, 10.1001/jama.2019.11645 Sep 3

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

AOPR | COVID-19和眼部并发症：眼部表现、诊断方法和预防策略综述

暂无数据